Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0935-0238
ICR Reference No:
201707-0935-003
Status:
Historical Active
Previous ICR Reference No:
Agency/Subagency:
HHS/AHRQ
Agency Tracking No:
Title:
The AHRQ Safety Program for Improving Antibiotic Use
Type of Information Collection:
New collection (Request for a new OMB Control Number)
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
09/25/2017
Retrieve Notice of Action (NOA)
Date Received in OIRA:
07/28/2017
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
09/30/2020
36 Months From Approved
Responses
56,372
0
0
Time Burden (Hours)
22,442
0
0
Cost Burden (Dollars)
0
0
0
Abstract:
Antibiotics can have serious adverse effects including Clostridium difficile infections (CDI), organ dysfunction, allergic reactions, and the development of antibiotic resistance on both a patient level and population level. This project will assist acute care, long-term care and ambulatory care settings across the United States in adopting and implementing antibiotic stewardship programs, which are coordinated efforts to improve the use of antibiotics by promoting the selection of the optimal antibiotic regimen, dose, route of administration, and duration of therapy. More specifically, this project has the following goals: • Identify best practices in the delivery of antibiotic stewardship in the acute care, long-term care and ambulatory care settings • Adapt the Comprehensive Unit-Based Safety Program (CUSP) model to enhance antibiotic stewardship efforts in the health care settings • Assess the adoption of CUSP for antibiotic stewardship and evaluate the effectiveness of the intervention in the participating health care systems • Develop a bundle of technical and adaptive interventions and associated tools and educational materials designed to support enhanced antibiotic stewardship efforts • Provide technical assistance and training to health care organizations nationwide, using a phased approach, to implement effective antibiotic stewardship programs and interventions • Improve communication and teamwork between health care workers surrounding antibiotic decision-making • Improve communication between health care workers and patients/families surrounding antibiotic decision-making
Authorizing Statute(s):
US Code:
42 USC 299
Name of Law: Healthcare Research and Quality Act of 1999
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
82 FR 21233
05/05/2017
30-day Notice:
Federal Register Citation:
Citation Date:
82 FR 34952
07/27/2017
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
10
IC Title
Form No.
Form Name
3. AHRQ Patient Safety Culture Surveys:c. NHSOPS (Cohort 3)
3c
Attachment G: The Nursing Home Survey on Patient Safety Culture (NHSOPS)
3. AHRQ Patient Safety Culture Surveys:d. MOSOPS (Cohort 4)
3d
Attachment H: The Medical Office Survey on Patient Safety Culture (MOSOPS)
AHRQ Patient Safety Culture Surveys:HSOPS, NHSOPS, MOSOPS (Cohort 1)
3a2, 3a3, 3a
Attachment F: The Hospital Survey on Patient Safety Culture (HSOPS)
,
Attachment G: The Nursing Home Survey on Patient Safety Culture (NHSOPS)
,
Attachment H: The Medical Office Survey on Patient Safety Culture (MOSOPS)
EHR data (Cohorts 1, 2, and 3)
Semi-structured qualitative interviews (Cohort 1): Other Health Practitioners
4 - b
Attachment J: Draft Interview Guide for Semi-Structured Interviews – Frontline workers
Semi-structured qualitative interviews (Cohort 1): Physicians
4 - I
Attachment I: Draft Interview Guide for Semi-Structured Interviews – Antibiotic
Structural Assessments – Cohort 4 (baseline)
b1. Structural Assessments – Cohort 4 (baseline)
Attachment B Structural Assessment for Ambulatory Care Setting
Structural Assessments – Cohorts 1, 2 and 3 (baseline, post-intervention)
a1 Structural Assessments – Cohorts 1, 2 and 3, a3 Structural Assessments – Cohorts 1, 2 and 3 , a2 Structural Assessments – Cohorts 1, 2 and 3
Attachment A: Structural Assessment for Acute Care Setting
,
a2 Structural Assessments – Cohorts 1, 2 and 3
,
Attachment C: Structural Assessment for Long Term Care Setting
Team Antibiotic Review Form (Cohorts 1, 2, and 3)
E, D
Attachment D: Team Antibiotic Review Form
,
Attachment E: Completion Guide for Team Antibiotic Review Form
The AHRQ Safety Program for Improving Antibiotic Use b. HSOPS (Cohort 2)
3b
Attachment F: The Hospital Survey on Patient Safety Culture (HSOPS)
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
56,372
0
0
56,372
0
0
Annual Time Burden (Hours)
22,442
0
0
22,442
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
This is a new ICR.
Annual Cost to Federal Government:
$1,983,765
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
Yes
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
Doris Lefkowitz 3014271477
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
07/28/2017
An official website of the United States government
The .gov means it's official.
The site is secure.
